Article preview from Medtech Insight - April, 2012
The field of women's health is one of the most progressive medical technology sectors in the US, driven by the aging population, diagnostic advances in deadly ovarian and colorectal cancer, and medical device innovations in gynecologic and urogynecologic disease management, including a shift toward minimally invasive surgery (MIS) techniques and robotics and the addition of a new field: bariatric gynecology. At the WH 2.0 Consensus Conference on Women's Health, held recently in Los Angeles, experts agreed that advances in medical technology are promising better detection and treatment of a host of diseases impacting both premenopausal and postmenopausal women. However, challenges remain in managing obesity-related disease and improving screening for often-undetected cancers in women.
Article preview from Medtech Insight - April, 2012
"No nation is healthier than its women": a telling statement by Ari Babaknia, MD, chairman of the Medical Advisory Board for the Los Angeles Center for Women's Health (LACWH), in his opening remarks at the inaugural WH 2.0 Consensus Conference on Women's Health, held February 9-11 in downtown Los Angeles. At this first-of-its-kind multidisciplinary event, organized by LACWH and the California Hospital Medical Center, thought-leading physicians and researchers discussed the very latest progress being made in the diagnosis and treatment of a wide variety of disorders that are poised to take a dramatic toll on women's health, and the already-strained US health care system, in the coming years.
The field of women's health is one of the most progressive medical technology sectors in the US, driven by the aging population, diagnostic advances in deadly ovarian and colorectal cancer, and medical device innovations in gynecologic and urogynecologic disease management, including a shift toward minimally invasive surgery (MIS) techniques and robotics. In addition, a whole new field in women's health has sprung out of the obesity epidemic: bariatric gynecology, and efforts have begun to identify women at high risk of a host of disorders associated with this costly chronic disease. At the WH 2.0 event, expert speakers agreed that advances in medical technology are promising better detection and treatment of a host of diseases impacting both premenopausal and postmenopausal women. However, challenges exist with managing obesity-related disease and improving screening for often-undetected cancers in women.
Continued...
To read this article in its entirety, purchase now as a PDF and receive it immediately via email. Or get it FREE when you subscribe to Medtech Insight Newsletter.
About Medtech Insight
Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices.
Comments